More than 90% of human PDACs bear Kirsten rat sarcoma virus (Kras) mutations, suggesting that this mutation may serve as an initiating point in pancreatic carcinogenesis, with other genetic mutations appearing during tumor progression [3]. The gene discussed is KRAS; the disease is neoplasm.